CD80 antibody (AA 227-245)
Quick Overview for CD80 antibody (AA 227-245) (ABIN2618750)
Target
See all CD80 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 227-245
-
Purification
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of rat CD80(227-245aa DAHVSQNFTWEKPPEDPPD), different from the related mouse sequence by two amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Rat
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Preservative
- Sodium azide, Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Handling Advice
- Avoid freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- CD80
-
Alternative Name
- CD80
-
Background
-
Name/Gene ID: CD80
Synonyms: CD80, Activation B7-1 antigen, B7-1, B7.1, BB1, CD28LG, CD28LG1, CD80 antigen, LAB7, CD80 Molecule, CTLA-4 counter-receptor B7.1 -
Gene ID
- 941
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-